<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Lazurus, David on c13u&#39;s Blog</title>
    <link>https://www.curiosities.dev/authors/lazurus-david/</link>
    <description>Recent content in Lazurus, David on c13u&#39;s Blog</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 22 Jan 2019 00:00:00 +0000</lastBuildDate><atom:link href="https://www.curiosities.dev/authors/lazurus-david/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Monopolistic Tendencies in the Prescription Glasses Industry</title>
      <link>https://www.curiosities.dev/health-and-medicine/2019-01-22-why-are-glasses-so-expensive/</link>
      <pubDate>Tue, 22 Jan 2019 00:00:00 +0000</pubDate>
      
      <guid>https://www.curiosities.dev/health-and-medicine/2019-01-22-why-are-glasses-so-expensive/</guid>
      <description>Luxottica - Queen of the Seven Kingdoms  Luxottica owns and licenses Armani, Brooks Brothers, Burberry, Chanel, Coach, DKNY, Dolce &amp;amp; Gabbana, Michael Kors, Oakley, Oliver Peoples, Persol, Polo Ralph Lauren, Ray-Ban, Tiffany, Valentino, Vogue and Versace.
Italy&amp;rsquo;s Luxottica also runs EyeMed Vision Care, LensCrafters, Pearle Vision, Sears Optical, Sunglass Hut and Target Optical. It also merged with the world&amp;rsquo;s leading maker of prescription eyeglass lenses and contact lenses, to form EssilorLuxottica.</description>
    </item>
    
  </channel>
</rss>
